Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00046501
Status:
COMPLETED
Last Update Posted:
2011-01-11
First Post:
2002-09-30
Brief Title:
Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Morning LANTUS v Intermediate-acting Insulin 2xDay as Basal Insulin in a Multiple Daily Inj w Humalog in Adolescents w Type 1 Diabetes Mellitus an Active-controlled Open Randomized Gender-stratified Two-arm Parallel-group Study
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to compare the effect in blood sugar control between Lantus and twice daily intermediate acting insulins NPH or Lente when used as the basal insulin in a multiple daily injection setting with fast acting insulin Lispro
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None